TelaDoc, the largest telehealth firm in the United States, saw its stock price nosedive by more than 60% in the past month. TelaDoc’s stock price is down 78% from its high last year. This is significant considering health care experts predicted telemedicine would get a huge boost from Covid and telehealth visits become mainstream. What’s behind the stock slide? Was it profit-taking by early investors or has the public’s interest in telehealth waned? By the way, TelaDoc was founded in Dallas in 2002 and funded my early policy work on telemedicine 15 years ago under different leadership.
Category: Telemedicine
Friday Links
Telemedicine is being used for assisted dying.
Why was a Texas woman charged with murder over a self-induced abortion?
Will 10,000 steps a day make you healthier? No. 7,000 steps seems to get the job done.
Why do companies invest in finding drugs to treat rare diseases?
How did the Middle Ages respond to the Back Death? With price controls and more. (recommended)
How COVID-19 Is Changing The Debate Over Health Reform
A revolution is occurring in the way medical care is being delivered in the United States. It is happening almost overnight. People have stopped going to hospital emergency rooms. They have stopped going to doctors’ offices. Most of the nation is self-isolating. Doctors and patients are no exception. They are communicating by means of phone, email, Skype, Zoom and other devices. Last December, Zoom was the host of 10 million video conferences a day. Last week, the company was hosting 200 million a day. Many of those were patient/doctor communications.